Clinical Study on the Effect of Zhenyuan Capsule on Cardiopulmonary Function in Patients With SCAD

Stable Coronary Heart Disease Clinical Trial

Official title:
Clinical Study on the Effect of Zhenyuan Capsule on Cardiopulmonary Function in Patients With Stable Coronary Heart Disease With Qi Deficiency and Blood Stasis

Status Not yet recruiting

Clinical Trial Summary

A randomized, double-blind, placebo trial was adopted, and cardiopulmonary exercise load test (CPET) was used to detect peak oxygen uptake (PeakVO2) and exercise metabolic equivalent (METs) to confirm the clinical effect of Zhenyuan capsule on improving cardiopulmonary endurance in patients with coronary heart disease of qi deficiency and blood stasis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04421287
Study type	Interventional
Source	Xiyuan Hospital of China Academy of Chinese Medical Sciences
Contact	NA HUAN, Master
Phone	0086
Email	HUANNA0323@163.com
Status	Not yet recruiting
Phase	Phase 4
Start date	June 1, 2020
Completion date	December 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02520466` - Cocoa Flavanol and Coronary Vasomotion Vascular Function in Patients With Coronary Artery Disease	N/A
Recruiting	`NCT04218487` - Xuefu-Zhuyu Capsule for the Treatment of "Qizhi Xueyu Zheng" (Qi Stagnation and Blood Stasis Syndrome)	Phase 4
Not yet recruiting	`NCT04308551` - Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Coronary Heart Disease	N/A
Completed	`NCT03351738` - A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease	Phase 2
Completed	`NCT02947542` - Use of Different Diagnostic Coronary Catheters Over the Radial Access - the UDDC - Radial Trial	N/A